Swedish Drug-elution Trial in Peripheral Arterial Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,556

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2026

Conditions
Peripheral Arterial DiseaseCritical Limb IschemiaIntermittent Claudication
Interventions
PROCEDURE

Revascularization with drug-eluting technology

Endovascular intervention with the use of drug-eluting devices (drug-coated balloons and/or drug-eluting stents).

PROCEDURE

Revascularization without drug-eluting technology

Endovascular intervention without using drug-eluting balloons or stents

DEVICE

drug-coated balloons and/or drug-eluting stents

Trial Locations (1)

41345

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Swedish Heart Lung Foundation

OTHER

collaborator

Uppsala University

OTHER

collaborator

The Swedish National Registry for Vascular Surgery

OTHER

lead

Sahlgrenska University Hospital

OTHER

NCT02051088 - Swedish Drug-elution Trial in Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter